Alert: European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite 'possible link" to rare blood clots

SeattlePI.com

20 Apr 2021 0 shares 1 views

Alert: European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite 'possible link

Alert: European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite 'possible link" to rare blood clots

SeattlePI.com

Published 20 Apr 2021

AMSTERDAM (AP) — European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite 'possible link" to rare blood clots.

You might like

Related news coverage

US health panel reviews J&J vaccine pause over rare clots

SeattlePI.com 23 Apr 2021

With the U.S. pause of Johnson & Johnson’s COVID-19 vaccine stretched into a second week, authorities are weighing whether to..

EU agency says people should get 2nd dose of AstraZeneca too
SeattlePI.com 23 Apr 2021
EU agency to issue more guidance on AstraZeneca's COVID shot
SeattlePI.com 23 Apr 2021
Norway lends AstraZeneca vaccine jabs to Sweden, Iceland
SeattlePI.com 22 Apr 2021
Johnson & Johnson to Resume European Union Vaccine Rollout
NYTimes.com 21 Apr 2021

Advertisement

More coverage

J. & J. to Resume E.U. Vaccine Rollout, With Warning of Rare Side Effect

NYTimes.com 20 Apr 2021

With the Johnson & Johnson vaccine paused in the United States, the European Union drug regulator found that the benefits outweigh..

EMA Says Benefits Outweigh The Clots Potentially Linked To Johnson & Johnson Vaccine
NPR 20 Apr 2021
EU agency links Johnson & Johnson shot to rare clots, says odds favor use
PIX 11 20 Apr 2021
EMA Says J&J Covid Vaccine's Benefits Outweigh Rare Blood Clot Risks
RTTNews 20 Apr 2021
EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots
NPR 20 Apr 2021